Merrimack Pharmaceuticals Inc. (MACK) Drops 6.99% on January 13

Equities Staff |

Merrimack Pharmaceuticals Inc. (MACK) was one of the Russell 2000's biggest losers for Wednesday January 13 as the stock slid 6.99% to $6.06, a loss of $-0.455 per share. Starting at an opening price of $6.53 a share, the stock traded between $6.03 and $6.71 over the course of the trading day. Volume was 1.32 million shares over 9,160 trades, against an average daily volume of 1.46 million shares and a total float of 115.57 million.

The losses send Merrimack Pharmaceuticals Inc. down to a market cap of $699.8 million. In the last year, Merrimack Pharmaceuticals Inc. has traded between $13.84 and $5.79, and its 50-day SMA is currently $8.44 and 200-day SMA is $10.35.

Merrimack Pharmaceuticals Inc is engaged in discovering, developing and preparing to commercialize medicines consisting of novel therapeutics paired with companion diagnostics for the treatment of cancer.

Merrimack Pharmaceuticals Inc. is based out of Cambridge, MA and has some 306 employees. Its CEO is Robert J. Mulroy.

For a complete fundamental analysis analysis of Merrimack Pharmaceuticals Inc., check out’s Stock Valuation Analysis report for MACK. To see the latest independent stock recommendations from’s analysts, visit our Research section.

The Russell 2000 is one of the leading indices tracking small-cap companies in the United States. It's maintained by Russell Investments, an industry leader in creating and maintaining indices, and consists of the smallest 2000 stocks from the broader Russell 3000 index.

Russell's indices differ from traditional indices like the Dow Jones Industrial Average (DJIA) or S&P 500, whose members are selected by committee, because they base membership entirely on an objective, rules based methodology. The 3,000 largest companies by market cap make up the Russell 3000, with the 2,000 smaller companies making up the Russell 2000. It's a simple approach that gives a broad, unbiased look at the small-cap market as a whole.

For more news on the financial markets, go to Also, learn more about our independent proprietary equity research reports and our robust do-it-yourself Stock Valuation Analysis reports in our Research section.

All data provided by QuoteMedia and was accurate as of 4:30PM ET.

DISCLOSURE: The views and opinions expressed in this article are those of the authors, and do not represent the views of Readers should not consider statements made by the author as formal recommendations and should consult their financial advisor before making any investment decisions. To read our full disclosure, please go to:


Emerging Growth

Gold Reach Resources Ltd.

Gold Reach Resources Ltd is engaged in the acquisition, exploration and development of mineral properties in British Columbia.

Private Markets


Airbnb is a community marketplace for people to list, discover, and book unique accommodations around the world — online or from a mobile phone. Whether an apartment for a night,…


D-Wave Systems is the first quantum computing company. Its mission is to integrate new discoveries in physics, engineering, manufacturing, and computer science into breakthrough approaches to computation to help solve…